ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,001Medicare Part D Prescriptions Filled, Including Refills

Rank: 167 out of 617

$316K Total Retail Price of All Prescriptions

Rank: 226 out of 617

433 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 433 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 6,657 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 341 281 1 4
LEVOTHYROXINE SODIUM 337 261 2 1
ATENOLOL 318 311 3 17
OMEPRAZOLE 318 252 3 3
LISINOPRIL 264 249 5 5
AMLODIPINE BESYLATE 238 212 6 6
METFORMIN HCL 236 181 7 9
SIMVASTATIN 223 205 8 2
WARFARIN SODIUM 221 214 9 7
HYDROCODONE-ACETAMINOPHEN 188 145 S3 10 8
GABAPENTIN 134 96 11 16
METOPROLOL SUCCINATE 132 122 12 12
DILTIAZEM ER 130 130 13 81
LOVASTATIN 116 114 14 57
POTASSIUM CHLORIDE 111 79 15 10
GLIPIZIDE ER 99 98 16 94
LOSARTAN POTASSIUM 98 87 17 22
METOPROLOL TARTRATE 95 85 18 11
CARVEDILOL 94 87 19 19
PAROXETINE HCL 90 75 20 62
HYDROCHLOROTHIAZIDE 87 79 21 13
GLIPIZIDE XL 83 79 22 147
ALLOPURINOL 81 70 23 27
ZOLPIDEM TARTRATE 77 55 24 23
PREDNISONE 73 70 25 31
TAMSULOSIN HCL 68 62 26 26
FAMOTIDINE 67 58 27 54
DONEPEZIL HCL 66 66 28 30
ISOSORBIDE MONONITRATE ER 64 61 29 52
FLUOXETINE HCL 64 58 29 73
MIRTAZAPINE 60 60 31 50
ATORVASTATIN CALCIUM 59 49 32 14
MELOXICAM 54 49 33 24
NAMENDA 54 44 33 35
SERTRALINE HCL 51 28 35 20
CRESTOR 51 47 35 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.